Exchange: NASDAQ·Updated 07:54 PM EDT
News
all
press releases
Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
More News
Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates
Illumina (ILMN) delivered earnings and revenue surprises of +6.50% and +3.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 PR Newswire SAN DIEGO, July 30, 2026 SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today...
PR Newswire
EXEL vs. ILMN: Which Stock Is the Better Value Option?
EXEL vs. ILMN: Which Stock Is the Better Value Option?
Zacks
Are Medical Stocks Lagging Celldex Therapeutics (CLDX) This Year?
Here is how Celldex Therapeutics (CLDX) and Illumina (ILMN) have performed compared to their sector so far this year.
Zacks
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.
Zacks
Illumina expands Billion Cell Atlas program with new AI drug developers
Illumina expands Billion Cell Atlas program with new AI drug developers Illumina expands Billion Cell Atlas program with new AI drug developers PR Newswire SAN DIEGO, July 16, 2026 Partners will use unprecedented data scale to advance more precise medicines to approvalSAN DIEGO, July 16, 2026...
PR Newswire
Here's Why Illumina (ILMN) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Biotech is gaining momentum as healthcare leads higher, with several drugmakers and life sciences companies showing improving earnings trends and breakouts.
Zacks
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 PR Newswire SAN DIEGO, July 9, 2026 SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that...
PR Newswire
<
1
2
>

Advertisement|Remove ads.